Gestational diabetes & diabetes in pregnancy
Gestational diabetes mellitus in women with polycystic ovary syndrome
Authors' conclusion
The prevalence of GDM in women with PCOS is not similar between those treated for infertility using ART and those not treated. Other determinants of GDM within this population have been identified, which could potentially enable early detection of women at risk and the implementation of personalized care in a precision medicine approach.
Study context
- Population
- Pregnant women with polycystic ovary syndrome (PCOS) followed up 1997–2024 at the university hospital centre where PCOS was diagnosed
- Participants
- 622 women
- Exposure
- Infertility-treated vs untreated women with PCOS
- Treatedn = 301
- Untreatedn = 321reference
- Outcome
- Prevalence of GDM
Methodological detailssingle-centre (university hospital centre)
- Single-centre (university hospital centre)
Main finding
As reported in the abstract
GDM prevalence
P = 0.04
- Gestational diabetes mellitus (GDM) prevalence in total population
- 32.5% (95% CI 28.8-36.3)
Observational data: associations, not effects.
Further findings
| Outcome | P value |
|---|---|
| Time to initiation of insulin therapySimilar | Log-rank test P = .83 |
Independent risk factors for GDM (logistic regression)
- Age, BMI, blood pressure, TG, testosterone and LH were independent risk factors for GDM
Original publication
Gestational diabetes mellitus in women with polycystic ovary syndrome. Diabetes Metab. Published 19 March 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →